Table 2

Participants' characteristics – disease related information (self reported)


Group A – clinical
Group B – DCCV


Crohn's disease
Ulcerative colitis
Crohn's disease
Ulcerative colitis

Disease duration (median)
9.0 yrs
6.0 yrs
13.0 yrs
9.0 yrs
Disease onset > 40 yrs
14 (16%)
3 (13%)
7 (6%)
6 (7%)
Disease onset < 18 yrs
16 (18%)
3 (13%)
28 (22%)
15 (17%)
Active disease
38 (42%)
19 (80%)
28 (22%)
31 (35%)
Mild disease course
22 (26%)
5 (23%)
44 (36%)
32 (37%)
Severe disease course
35 (42%)
7 (32%)
45 (37%)
21 (24%)
Past resecting surgery
38 (42%)
1 (4%)
73 (57%)
10 (11%)
Ostomy
10 (11%)
1 (4%)
13 (10%)
4 (5%)
Ileocecal resection
27 (30%)

48 (37%)

Perianal disease, current
19 (22%)

26 (21%)

Perianal disease, ever
23 (27%)

36 (28%)

Currently on steroids
39 (44%)
11 (48%)
35 (28%)
25 (28%)
Other immunosuppression
18 (20%)
6 (25%)
43 (34%)
19 (21%)
Total/substantial Colitis

14 (64%)

44 (49%)
Left sided colitis

5 (23%)

29 (33%)
Proctitis only

3 (14%)

16 (18%)
Small bowel only
14 (19%)

25 (20%)

Large bowel only
14 (19%)

37 (29%)

Combined disease
41 (56%)

61 (48%)

Upper Gi Involvement
4 (5%)

5 (4%)


N
90
24
129
93

Not all categories shown for most variables, missing values not reported

Timmer et al. BMC Gastroenterology 2008 8:45   doi:10.1186/1471-230X-8-45